COVID-19 Updates
Latest News
COVID-19 antibody drug likely works against Omicron, companies say
The preliminary findings haven’t yet been peer-reviewed.
From the Journals
Celiac disease and COVID-19: Reassuring data on outcomes
“This is the largest study characterizing CD patients with COVID-19 to date to systematically investigate outcomes of CD patients with COVID-19...
Feature
Ten changes that could keep clinicians in the workforce in a pandemic
Doctors make checklist of low-cost action items to start addressing a wave of providers leaving medicine.
Latest News
Second U.S. COVID-19 case caused by Omicron found
“This news is concerning, but it is not a surprise.”
Latest News
Rapid COVID-19 tests will soon be covered by insurance
The measures are part of a suite of new actions President Joe Biden is expected to announce later today, Dec. 2, in the wake of the arrival of the...
Feature
For older adults, smelling the roses may be more difficult
According to new estimates, up to 1.6 million Americans have chronic olfactory dysfunction due to COVID-19.
Latest News
First Omicron variant case identified in U.S.
“All close contacts have been contacted and have tested negative.”
Latest News
Moderna warns of material drop in vaccine efficacy against Omicron
“There is no world, I think, where [the effectiveness] is the same level … we had with Delta.”
Latest News
Fauci: Omicron ‘very different from other variants’
“Although partial immune escape may occur, vaccines, particularly boosters, give a level of antibodies that even with variants like Delta give you...
News
FDA panel backs first pill for COVID-19 by a small margin
If authorized by the agency, molnupiravir would be first antiviral agent available as a pill to treat COVID-19.
Commentary
We physicians must pull together as a knowledge community
Intelligent, thoughtful, and highly respected scientists, researchers, and physicians must have room to safely share their knowledge and clinical...